1 Under-the-Radar Pharma Stock with 90% Upside?
Billionaire Stanley Druckenmiller has been making large changes to his portfolio recently, leaving retail investors struggling to keep up with what the famous stock picker is thinking.
One of the smaller holdings in Druckenmiller’s portfolio that makes for interesting examination is ARS Pharmaceuticals (NASDAQ:SPRY).
Druckenmiller’s 536,900 shares of SPRY are currently valued at around $7 million. » Read more about: 1 Under-the-Radar Pharma Stock with 90% Upside? »
Read More
Why Bitcoin Will Moon
If you’re on the sideline wondering where bitcoin will go, we’re about to demystify it.
Warren Buffett famously described bitcoin as “rat poison squared” and a major reason for that view was the cryptocurrency’s failure to produce cash flows, or anything else really.
Buffett was viewing bitcoin more like an asset than something more elementary,
» Read more about: Why Bitcoin Will Moon »
Read More
Champion Trader vs Cathie Wood: Who Wins?
A battle between a great trader and a prominent money manager has taken place in recent years. Mark Minervini, 2x US trading champion, has taken shots at billion dollar money manager, Cathie Wood of ARK Invest.
His primary critique appears to be based in a rule that he has observed over time. A stock that has fallen 80% can decline by another 50%.
» Read more about: Champion Trader vs Cathie Wood: Who Wins? »
Read More
How Zuckerberg Can Seize The Next Trillion
CEO Mark Zuckerberg doesn’t get as much credit as he may deserve for his ferocity and tenaciousness. As the head of Meta, he is widely viewed as the dorky tech guy who stumbled upon a great idea and just happened to build a big social media business.
The truth is he’s a harsh competitor,
» Read more about: How Zuckerberg Can Seize The Next Trillion »
Read More
Will NVIDIA Be Knocked Off Its Perch By Quantum?
Earlier this month, NVIDIA CEO Jensen Huang seemingly dashed the hopes of speculative tech investors banking on quantum computing to become the next big thing in the ever-advancing race for faster and faster computer processing. Huang, speaking at the Consumer Electronics Show, stated his view that practical quantum computers were still about two decades away,
» Read more about: Will NVIDIA Be Knocked Off Its Perch By Quantum? »
Read MoreThe Ivy
Will Palantir Split After Soaring 15x In 2 Years?
Shares of Palantir Technologies (NASDAQ:PLTR) have skyrocketed over the last year, gaining over 345% and handing shareholders returns that massively outperformed the stock market as a whole.
With such enormous gains under its belt, some investors are understandably curious about the possibility of a Palantir stock split. Today, we’ll look at whether a split is likely for PLTR shares or if the company will allow its shares to keep moving higher.
» Read more about: Will Palantir Split After Soaring 15x In 2 Years? »
Read MoreThe Spotlight
Major European Fintech with 36% Upside?
Euronet Worldwide (NASDAQ: EEFT) isn’t particularly well-known on US shores but it sits at the intersection of financial technology and the growing demand for cross-border transactions.
If you’re not already familiar with the firm it has a pretty diverse portfolio of financial technology services that encompass ATMs,
» Read more about: Major European Fintech with 36% Upside? »
Read MoreThe Daily
Bio-Techne (TECH) Receives a Buy from Leerink Partners
Leerink Partners analyst Puneet Souda maintained a Buy rating on Bio-Techne (TECH – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $48.10.
Stay Ahead of the Market:
According to TipRanks,
» Read more about: Bio-Techne (TECH) Receives a Buy from Leerink Partners »